Point72 Hong Kong’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $244K | Sell |
5,000
-17,273
| -78% | -$844K | 0.02% | 283 |
|
|
2025
Q1 | $1.14M | Sell |
22,273
-10,163
| -31% | -$518K | 0.07% | 184 |
|
|
2024
Q4 | $1.46M | Buy |
32,436
+21,034
| +184% | +$949K | 0.09% | 156 |
|
|
2024
Q3 | $423K | Sell |
11,402
-46,128
| -80% | -$1.71M | 0.03% | 245 |
|
|
2024
Q2 | $1.76M | Buy |
57,530
+48,307
| +524% | +$1.48M | 0.11% | 152 |
|
|
2024
Q1 | $268K | Buy |
+9,223
| New | +$268K | 0.01% | 378 |
|
|
2022
Q4 | – | Sell |
-8,305
| Closed | -$417K | – | 951 |
|
|
2022
Q3 | $417K | Buy |
8,305
+4,283
| +106% | +$215K | 0.01% | 409 |
|
|
2022
Q2 | $161K | Buy |
+4,022
| New | +$161K | 0.01% | 628 |
|
|
2022
Q1 | – | Sell |
-2,804
| Closed | -$112K | – | 1715 |
|
|
2021
Q4 | $112K | Buy |
+2,804
| New | +$112K | ﹤0.01% | 611 |
|
|
2021
Q3 | – | Sell |
-624
| Closed | -$26K | – | 1743 |
|
|
2021
Q2 | $26K | Buy |
624
+216
| +53% | +$9K | ﹤0.01% | 1033 |
|
|
2021
Q1 | $19K | Buy |
+408
| New | +$19K | ﹤0.01% | 973 |
|
|
2019
Q4 | – | Sell |
-808
| Closed | -$27K | – | 1390 |
|
|
2019
Q3 | $27K | Buy |
+808
| New | +$27K | 0.01% | 666 |
|
|
2018
Q4 | – | Sell |
-2,924
| Closed | -$137K | – | 1140 |
|
|
2018
Q3 | $137K | Buy |
+2,924
| New | +$137K | 0.05% | 277 |
|
|
2018
Q2 | – | Sell |
-1,276
| Closed | -$35K | – | 1125 |
|
|
2018
Q1 | $35K | Buy |
+1,276
| New | +$35K | 0.02% | 534 |
|
|
2017
Q2 | – | Sell |
-2,388
| Closed | -$23K | – | 996 |
|
|
2017
Q1 | $23K | Buy |
2,388
+2,340
| +4,875% | +$22.5K | 0.03% | 382 |
|
|
2016
Q4 | $1K | Buy |
+48
| New | +$1K | ﹤0.01% | 818 |
|